Search for author "JoAnn E. Manson"
678 Results
- Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association. 2017;6:e004947, originally published June 29, 2017https://doi.org/10.1161/JAHA.116.004947
- Table 1.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu Qi
- Table 2.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu Qi
- Figure 1.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu Qi
- Figure 2.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu QiPooled relative risks of high trimethylamine N‐oxide (TMAO) levels for the risk of major adverse clinical events/death (A) and all‐cause mortality (B)...Show MorePooled relative risks of high trimethylamine N‐oxide (TMAO) levels for the risk of major adverse clinical events/death (A) and all‐cause mortality (B). Dashed lines represent the overall effect, and gray boxes represent weight. ES indicates effect size; RR, relative risk.Show Less
- Table 3.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu Qi
- Table 4.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu Qi
- Figure 3.Open AccessGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective StudiesYoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode, Lu QiJournal of the American Heart Association July 2017, 6 (7) e004947; DOI: https://doi.org/10.1161/JAHA.116.004947By Yoriko Heianza, Wenjie Ma, JoAnn E. Manson, Kathryn M. Rexrode and Lu QiPooled relative risks of elevated concentrations of l‐carnitine or choline (A) and betaine (B) for major adverse cardiovascular events/death. Dashed l...Show MorePooled relative risks of elevated concentrations of l‐carnitine or choline (A) and betaine (B) for major adverse cardiovascular events/death. Dashed lines represent the overall effect, and gray boxes represent weight. ES indicates effect size; RR, relative risk.Show Less
- You have accessRestricted accessPsychosocial Factors and Cardiovascular Disease RiskAn Opportunity in Women’s HealthOlivia I. Okereke and JoAnn E. MansonCirculation Research. 2017;120:1855-1856, originally published June 8, 2017https://doi.org/10.1161/CIRCRESAHA.117.311113
- Change in Physical Activity and Sitting Time After Myocardial Infarction and Mortality Among Postmenopausal Women in the Women's Health Initiative‐Observational StudyAnna M. Gorczyca, Charles B. Eaton, Michael J. LaMonte, JoAnn E. Manson, Jeanne D. Johnston, Aurelian Bidulescu, Molly E. Waring, Todd Manini, Lisa W. Martin, Marcia L. Stefanick, Ka He, Andrea K. ChomistekJournal of the American Heart Association. 2017;6:e005354, originally published May 15, 2017https://doi.org/10.1161/JAHA.116.005354
Pages
Journal
Source
- JAHA: Journal of the American Heart Association 54
- Arteriosclerosis, Thrombosis, and Vascular Biology 75
- Circulation: Arrhythmia and Electrophysiology 26
- Circulation: Cardiovascular Quality and Outcomes 66
- Circulation: Heart Failure 40
- Circulation Research 8
- Circulation 181
- Hypertension 122
- Stroke 106
Article Type
Article Type
- Acute Cerebral Hemorrhage 3
- Acute Cerebral Infarction 16
- Acute Stroke Syndromes 4
- Acute myocardial infarction 13
- Ancel Keys Memorial Lecture: Diet and CVD Risk 3
- Arrhythmia and Electrophysiology 5
- Arrhythmias, clinical electrophysiology, drugs 13
- Article 30
- Atherosclerosis 14
- Atherosclerosis and Lipoproteins 22
- Atrial Fibrillation 2
- Behavioral/psychosocial - treatment 7
- Biomarkers 5
- CT and MRI 6
- CV surgery: other 7
- Cardiology Patient Page 4
- Cardiovascular Disease 5
- Cardiovascular Disease in Women 3
- Cardiovascular Pharmacology 6
- Cell signalling/signal transduction 7
- Cerebrovascular disease/stroke 10
- Chronic ischemic heart disease 12
- Clinical Investigation and Reports 10
- Clinical Sciences 12
- Clinical Studies 30
- Clinical Trial 14
- Clinical and Population Studies 37
- Clinical genetics 7
- Computerized tomography and Magnetic Resonance Imaging 6
- Congestive 18
- Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle 16
- Core 2: Epidemiology and Prevention of CV Disease: Physiology, Pharmacology, and Lifestyle 4
- Coronary Heart Disease 13
- Coronary circulation 6
- Correspondence 3
- Diabetes 2
- Diabetic CVD: Clinical and Experimental II 2
- Dietary Factors, Exercise, and Cardiovascular Risk 26
- Editorial 5
- Electrocardiology 17
- Elizabeth Barrett-Connor Research Award in Epidemiology and Prevention for Investigators in Training 2
- Embolic stroke 6
- Epidemiology 174
- Epidemiology and Prevention 8
- Epidemiology, Population & Big Data 2
- Epidemiology/Population Science 14
- Exercise/exercise testing/rehabilitation 5
- Gender and Ethnic Factors in CHD 2
- Genetics of cardiovascular disease 7
- Health policy and outcome research 4
- International Stroke Conference Poster Abstracts 2
- Ion channels/membrane transport 7
- Journal Article 4
- Lifestyle Risk Factors and Behavior Change 3
- Moderated Poster Abstract Presentations 15
- Nutrition 6
- Obesity 4
- Oral Abstract Presentations 11
- Original Article 87
- Original Articles 67
- Original Articles Original Article Original Articles 40
- Original Articles Original Article Original Articles Epidemiology/Population Science 3
- Original Contribution 6
- Original Contributions 56
- Original Contributions Original Contribution Original Contributions Clinical Sciences 6
- Original Contributions; Clinical Sciences 28
- Original Research 46
- Original Research Article 6
- Other Ethics and Policy 7
- Other Stroke Treatment - Medical 4
- Other etiology 10
- Other hypertension 13
- Other myocardial biology 7
- Pathophysiology 6
- Population Health Cohorts - Big Data 3
- Population Science 13
- Population Studies/Epidemiology 12
- Poster Abstract Presentations 29
- Postmenopausal Cardiovascular Risk 14
- Prevention 4
- Primary and Secondary Stroke Prevention 16
- Primary prevention 45
- Randomized Controlled Trial 3
- Research Letters 14
- Research Support, U.S. Gov't, P.H.S. 4
- Review 7
- Risk Factors 44
- Risk Factors for Stroke 19
- Scientific Contributions 24
- Session Title: Biomarkers 7
- Session Title: Metabolomics/Proteomics and CVD 3
- Session Title: Nutrition 4
- Session Title: Nutrition 2 6
- Stroke in Children and the Young 6
- Systematic Review and Meta‐Analysis 8
- Thrombosis 5
- Type 2 diabetes 7
- Volume 127, Issue 12 Supplement; March 26, 2013/Abstracts From the American Heart Association’s Epidemiology and Prevention/Physical Activity, Nutrition and Metabolism 2013 Scientific Sessions 10
- Volume 128, Issue 22 Supplement; November 26, 2013 / Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium 3
- Women 5
Subject
Subject
- ACE/Angiotension receptors 2
- AHA Statements and Guidelines 2
- Acute Cerebral Hemorrhage 11
- Acute Cerebral Infarction 45
- Acute Stroke Syndromes 15
- Acute coronary syndromes 4
- Acute myocardial infarction 57
- Aging 5
- Arrhythmias, clinical electrophysiology, drugs 42
- Behavioral Changes and Stroke 6
- Behavioral/psychosocial - stroke 4
- Behavioral/psychosocial - treatment 15
- Biomarkers 10
- CT and MRI 12
- CV surgery: coronary artery disease 2
- CV surgery: other 14
- Cardiovascular Disease 36
- Cardiovascular Pharmacology 15
- Cell signalling/signal transduction 14
- Cerebrovascular disease/stroke 26
- Chronic ischemic heart disease 43
- Clinical Studies 60
- Clinical genetics 15
- Coagulation 7
- Coagulation and fibronolysis 1
- Computerized tomography and Magnetic Resonance Imaging 12
- Congestive 39
- Coronary circulation 12
- Electrocardiology 34
- Embolic stroke 12
- Endothelium/vascular type/nitric oxide 2
- Epidemiology 364
- Exercise 5
- Exercise testing 1
- Exercise/exercise testing/rehabilitation 11
- Genetics of cardiovascular disease 14
- Health policy and outcome research 8
- Heart Failure 4
- Hypertension - basic studies 1
- Intracerebral Hemorrhage 1
- Ion channels/membrane transport 14
- Ischemic Stroke 5
- Lifestyle 7
- Lipid and lipoprotein metabolism 1
- Lipids 8
- Mental Health 1
- Nutrition 24
- Obesity 10
- Other Ethics and Policy 14
- Other Stroke Treatment - Medical 8
- Other Treatment 3
- Other etiology 21
- Other hypertension 28
- Other myocardial biology 14
- Pathophysiology 14
- Primary Prevention 3
- Primary and Secondary Stroke Prevention 33
- Primary prevention 110
- Quality and Outcomes 5
- Race and Ethnicity 4
- Risk Factors 151
- Risk Factors for Stroke 45
- Secondary prevention 2
- Stroke in Children and the Young 12
- Thrombosis 10
- Treatment 7
- Type 1 diabetes 1
- Type 2 diabetes 14
- Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 2
- Volume 127, Issue 12 Supplement; March 26, 2013/Abstracts From the American Heart Association’s Epidemiology and Prevention/Physical Activity, Nutrition and Metabolism 2013 Scientific Sessions 10
- Volume 128, Issue 22 Supplement; November 26, 2013 / Abstracts From the American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium 3
- Women 28
Content Type
Resource Type
- Articles 242
- Tables & Figures 408
- HWTABLE 28


